By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Swedish Orphan Biovitrum 

SE-112

  76 Stockholm    Sweden
Phone: 46-8-697-20-00 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Swedish Orphan Biovitrum's Board Of Directors Exercises Its Authorization For Repurchase Of Shares To Secure The Company’s Commitments Under The Incentive Programme 7/15/2016 11:10:39 AM
Swedish Orphan Biovitrum: Sobi Publishes Its Report For The Second Quarter 2016 7/15/2016 7:56:38 AM
Swedish Orphan Biovitrum: Health Canada Validates Orfadin Capsule Filing 7/14/2016 10:22:20 AM
Invitation -- Presentation Of Swedish Orphan Biovitrum’s Second Quarter Results 2016 7/6/2016 9:01:21 AM
Swedish Orphan Biovitrum: Orfadin 20 Mg Capsule Approved In The U.S. 6/15/2016 8:22:58 AM
Swedish Orphan Biovitrum: Sobi: First Alprolix Sales In The EU 6/6/2016 12:00:55 PM
Swedish Orphan Biovitrum Initiates Disclosure Of Payments To The Healthcare Industry To Increase Transparency 5/31/2016 11:47:43 AM
Swedish Orphan Biovitrum: Sobi's CEO Divests A Portion Of Incentive Shares 5/16/2016 11:27:30 AM
Swedish Orphan Biovitrum: Alprolix (rFIXFc) Approved In The EU For The Treatment Of Hemophilia B 5/13/2016 8:55:43 AM
Swedish Orphan Biovitrum (publ): Bo Jesper Hansen Sells 8 Million Shares 5/4/2016 9:26:05 AM
12345678910...
//-->